Pancreatic functions in high salt fed female rats

Physiological Reports

Volumn 3, Issue 7, 2015, Pages

  Lasheen, Noha N ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Amylase; High salt; IL6; Insulin; Lipase; TGF 1

Indexed keywords

ALDOSTERONE; AMYLASE; INSULIN; INTERLEUKIN 6; POTASSIUM; SODIUM; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL LIPASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOCRINE FUNCTION; FEMALE; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; ORGAN INJURY; PANCREAS FUNCTION; RAT; SALT INTAKE; SALT STRESS;

EID: 85006154514     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12443     Document Type: Article

References (53)

1. Aghdassi, A. A., J. Mayerle, S. Christochowitz, F. U. Weiss, M. Sendler, and M. M. Lerch. 2011. Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair 4:26.
2. Andersen, D. K. 2007. Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas 35:1–15.
3. Aoki, H., H. Ohnishi, K. Hama, S. Shinozaki, H. Kita, H. Yamamoto, et al. 2006a. Existence of autocrine loop between interleukin-6 and transforming growth factor-b1 in activated rat pancreatic stellate cells. J. Cell. Biochem. 99:221–228.
4. Aoki, H., H. Ohnishi, K. Hama, T. Ishijima, Y. Satoh, K. Hanatsuka, et al. 2006b. Autocrine loop between TGF-beta1 and IL-1beta through Smad3-and ERK-dependent pathways in rat pancreatic stellate cells. Am. J. Physiol. Cell Physiol. 290:C1100–C1108.
5. Apte, M., R. Pirola, and J. Wilson. 2009. New insights into alcoholic pancreatitis and pancreatic cancer. J. Gastroenterol. Hepatol. 24:S51–S56.
6. Baudrand, R., C. Campino, C. A. Carvajal, O. Olivieri, G. Guidi, G. Faccini, et al. 2014. High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin. Endocrinol. (Oxf) 80:677–684.
7. Bernardis, L. L. 1970. Prediction of carcass fat, water and lean body mass from Lee’s nutritive ratio in rats with hypothalamic obesity. Experientia 26:789–790.
8. Blaine, S. A., K. C. Ray, K. M. Branch, P. S. Robinson, R. H. Whitehead, and A. L. Means. 2009. Epidermal growth factor receptor regulates pancreatic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 297:G434–G441.
9. Bonora, E., G. Targher, M. Alberiche, R. C. Bonadonna, F. Saggiani, M. B. Zenere, et al. 2000. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63.
10. Border, W. A., and N. A. Noble. 1994. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331:1286–1292.
11. Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor b1. Nature 346:371–374.
12. Bouman, A., M. J. Heineman, and M. M. Faas. 2005. Sex hormones and the immune response in humans. Hum. Reprod. Update 11:411–423.
13. Brilla, C. G., and K. T. Weber. 1992. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 120:893–901.
14. Colussi, G., C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi. 2007. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 30:2349–2354.
15. Conrad, C. H., W. W. Brooks, J. A. Hayes, S. Sen, K. G. Robinson, and O. H. Bing. 1995. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 91: 161–170.
16. Ferreira, D. N., I. A. Katayama, I. B. Oliveira, K. T. Rosa, L. N. S. Furukawa, M. S. Coelho, et al. 2010. Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats. J. Nutr. 140:1742–1751.
17. Fielding, C. A., G. W. Jones, R. M. McLoughlin, L. McLeod, V. J. Hammond, J. Uceda, et al. 2014. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40:40–50.
18. Fonseca-Alaniz, M. H., J. Takada, S. Andreotti, T. B. F. de Campos, A. B. Campana, C. N. Borges-Silva, et al. 2008. High sodium intake enhances insulin-stimulated glucose uptake in rat epididymal adipose tissue. Obesity 16:1186–1192.
19. Forman, J. P., L. Scheven, P. E. de Jong, S. J. L. Bakker, G. C. Curhan, and R. T. Gansevoort. 2012. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125:3108–3116.
20. Gonzalez, M., L. Lobos, F. Castillo, L. Galleguillos, N. C. Lopez, and L. Michea. 2005. High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries. Hypertension 45:853–859.
21. Kahn, S. E., R. L. Hull, and K. M. Utzschneider. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846.
22. Kanbay, M., Y. Chen, Y. Solak, and P. W. Sanders. 2011. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr. Opin. Nephrol. Hypertens. 20:37–43.
23. Keller, J., A. A. Aghdassi, M. M. Lerch, J. V. Mayerle, and P. Layer. 2009. Tests of pancreatic exocrine function-clinical significance in pancreatic and non-pancreatic disorders. Best Pract. Res. Clin. Gastroenterol. 23:425–439.
24. Lal, A., J. P. Veinot, and F. H. Leenen. 2003. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. Am. J. Hypertens. 16:319–323.
25. Liu, Q., L. Adams, A. Broyde, R. Fernandez, A. D. Baron, and D. G. Parkes. 2010. The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats. Cardiovasc. Diabetol. 9:32.
26. Longnecker, D. S. 1982. Pathology and pathogenesis of diseases of the pancreas. Am. J. Pathol. 107:99–121.
27. Lorrell, B. H. 1997. Transition from hypertrophy to failure. Circulation 96:963824–963827.
28. Luther, J. M. 2011. Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia 54:2152–2163.
29. Luther, J. M., Z. Wang, J. Ma, N. Makhanova, H. S. Kim, and N. J. Brown. 2009. Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta. Endocrinology 150:2229–2236.
30. Madero, M., S. Perez-Pozo, D. Jalal, R. J. Johnson, and L. G. Sanchez-Lozada. 2011. Dietary fructose and hypertension. Curr. Hypertens. Rep. 13:29–35.
31. Makhanova, N., G. Lee, N. Takahashi, M. L. Sequeira Lopez, R. A. Gomez, H. S. Kim, et al. 2006. Kidney function in mice lacking aldosterone. Am. J. Physiol. Renal. Physiol. 290:F61–F69.
32. Matavelli, L. C., X. Zhou, J. Varagic, D. Susic, and E. D. Frohlich. 2007. Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 292:H814–H819.
33. McMurray, J. J., R. R. Holman, S. M. Haffner, M. A. Bethel, B. Holzhauer, T. A. Hua, et al. 2010. Effect of valsartan on the incidence of diabetes and cardiovascular events. N. Engl. J. Med. 362:1477–1490.
34. Messerli, F. H., R. E. Schmieder, and M. R. Weir. 1997. Salt. A perpetrator of hypertensive target organ disease? Arch. Intern. Med. 157:2449–2452.
35. Morizane, S., F. Mitani, K. Ozawa, K. Ito, T. Matsuhashi, Y. Katsumata, et al. 2012. Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in Dahl salt-sensitive rats. Arterioscler. Thromb. Vasc. Biol. 32:1194–1203.
36. Mosso, L. M., C. A. Carvajal, A. Maiz, E. H. Ortiz, C. R. Castillo, R. A. Artigas, et al. 2007. A possible association between primary aldosteronism and a lower b-cell function. J. Hypertens. 25:2125–2130.
37. Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, et al. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121–124.
38. Ogihara, T., T. Asano, K. Ando, Y. Chiba, N. Sekine, H. Sakoda, et al. 2001. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 50:573–583.
39. Ohta, Y., T. Tsuchihashi, K. Kiyohara, and H. Oniki. 2013. High salt intake promotes a decline in renal function in hypertensive patients: a 10-year observational study. Hypertens. Res. 36:172–176.
40. Pergola, C., G. Dodt, A. Rossi, E. Neunhoeffer, B. Lawrenz, H. Northoff, et al. 2008. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc. Natl Acad. Sci. USA 105:19881–19886.
41. Riesle, E., H. Friess, L. Zhao, M. Wagner, W. Uhl, K. Baczako, et al. 1997. Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut 40:73–79.
42. Rocha, R., C. T. Stier Jr, I. Kifor, M. R. Ochoa-Maya, H. G. Rennke, G. H. Williams, et al. 2000. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141:3871–3878.
43. Sandler, S., K. Bendtzen, D. L. Eizirik, and M. Welsh. 1990. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology 126:1288–1294.
44. Sathyanarayan, G., P. K. Garg, H. Prasad, and R. K. Tandon. 2007. Elevated level of interleukin-6 predicts organ failure and severe disease in patients with acute pancreatitis. J. Gastroenterol. Hepatol. 22:550–554.
45. Sofola, O. A., A. Knill, R. Hainsworth, and M. Drinkhill. 2002. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J. Physiol. 543:255–260.
46. Spörri, B., K. M. Müller, U. Wiesmann, and M. Bickel. 1999. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int. Immunol. 11:1053–1058.
47. Takeda, Y., T. Yoneda, M. Demura, I. Miyamori, and H. Mabuchi. 2000. Sodium induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 141:1901–1904.
48. Visser, F. W., J. A. Krikken, J. H. Muntinga, R. A. Dierckx, and G. J. Navis. 2009. Rise in extracellular fluid volume during high sodium depends on BMI in healthy men. Obesity (Silver Spring) 17:1684–1688.
49. Vonlaufen, A., Z. Xu, B. Daniel, R. K. Kumar, R. Pirola, J. Wilson, et al. 2007. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology 133:1293–1303.
50. Weber, K. 1997. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin. Nephrol. 17:467–491.
51. Yeo, C. J., J. A. Bastidas, R. E. Schmieg Jr, S. Walfisch, N. F. Couse, J. L. Olson, et al. 1989. Pancreatic structure and glucose tolerance in a longitudinal study of experimental pancreatitis-induced diabetes. Ann. Surg. 210:150–158.
52. Ying, W. Z., and P. W. Sanders. 1998. Dietary salt modulates renal production of transforming growth factor- beta in rats. Am. J. Physiol. 274(4 Pt, 2):F635–F641.
53. Yu, H. C., L. M. Burrell, M. J. Black, L. L. Wu, R. J. Dilley, M. E. Cooper, et al. 1998. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621–2628.